Cytogen/Matritech BladderChek
This article was originally published in The Gray Sheet
Executive Summary
Restructured marketing agreement calls for Cytogen to target oncologists while Matritech focuses on urologists. The point-of-care, urine-based bladder cancer screening test was 510(k)-cleared last July (1"The Gray Sheet" May 5, 2003, p. 25)...